Blood Pressure Intelligence for Global Health Blood pressure was never meant to be understood from one reading. A single number, taken once in a clinic, tells you where you stood in that moment — not how your blood pressure actually behaves. We believe understanding comes from patterns: how blood pressure changes throughout the day, across sleep, activity and everyday life. Our vision: A world where no lives are lost or damaged by the effects of high blood pressure. Our mission: To help people better understand their blood pressure through greater visibility, context and awareness. Founded in 2018 by scientists from …

69 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Detect Alzheimer's earlier, when it could be prevented AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing accurate blood diagnoses and the next generation of precision therapies to treat Alzheimer’s. ALzheimer's disease, Biotechnology, Diagnosis, Machine learning, and AI

75 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Machine Learning

Your personal healthcare assistant Cardiogram is building your personal healthcare assistant, using Deep Learning to turn consumer wearables—like the Apple Watch, Android Wear, and Garmin devices—into continuous health monitors that can be used to not only track sleep and fitness, but may one day prevent a stroke and save your life. We can now detect 4 medical conditions using consumer wearables: Sleep Apnea, High Blood Pressure, Atrial Fibrillation, and even Diabetes. We’ve been running clinical studies with UCSF Cardiology since 2016, have published in JAMA, NIPS, AAAI, and our work has been featured in the WSJ, Wired, CNBC, TechCrunch, and …

327 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Deep Learning

The Calprotectin company Calpro AS was founded by the inventors of the technology behind the ELISA kits for determination of calprotectin in stools and other biological materials. The company is based in Oslo and has the benefit of close professional links with many of the major clinical research departments and medical establishments in Norway, Europe and the USA. Calpro AS provides high quality total solution for Calprotectin analysis. From fully automated system, to home monitoring of patients with IBD. The CalproLabTMELISA kit is validated for testing on faeces, plasma/serum samples, enabling among others assessment of IBD, rheumatic diseases and distinction …

59 similar entities Type: SMB Activities: deeptech healthtech biotech

Say goodbye to finger pricking! Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your …

64 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The Pioneer of Mobile Health iXensor is the pioneer of mobile health. We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA-approved smartphone camera-based blood test dated back in 2017. The founding team of iXensor first met at Stanford University in 2011. At that time, they saw the rise of the smartphone and its potential to reshape future healthcare. In 2012, iXensor was founded in Silicon Valley and then incorporated in Taipei, Taiwan. Our interdisciplinary team combines expertise in medical engineering, biochemistry, and …

253 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics

Ensuring every patient, provider, and payer benefit from our services. Precision Diagnostics is the only U.S. laboratory to have invested in and committed to deploying the most advanced, ultra-high sensitivity LC-MS/MS technology for clinical urine and oral fluid drug testing. Our accredited laboratory’s automated processes virtually eliminate human error, ensure fast turnaround times, and permit our scientists to focus on the data that merit their attention. Our testing methodology gives clinicians a better possibility of ensuring patient compliance and improving outcomes. We provide world-class client support and an analytics platform which delivers actionable data in a format that supports clinical …

153 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics

The new standard in heart failure management Acorai is developing a device for heart failure management through non-invasive cardiac and pulmonary pressure sensing, to help reduce hospitalizations and readmissions. Our product can monitor cardiac and pulmonary pressure sensing non-invasively through a machine-learning analysis of pressure dynamics in acoustics, vibratory, and waveform data. Our technology shows compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement, and a fast track to commercialization. Cardiology, Heart Failure, Heart Failure Monitoring, Medical Device, AI, Machine Learning, Heart Failure Patient Workflow, Prevent heart failure readmissions, Multi-sensor hardware, Pressure dynamics, Clinically proven …

122 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning

Predictive Data to Preserve Health CardiaMetrics is a French medtech company based in Caen and Grenoble, dedicated to addressing the global epidemic of heart failure. Our ambition is clear: to maintain heart failure patients stable, prevent decompensation episodes, and reduce avoidable hospitalizations. We combine two breakthrough innovations: • A minimally invasive subcutaneous sensor that ensures reliable, continuous monitoring without requiring active patient engagement. • An artificial intelligence algorithm that provides healthcare teams with predictive intracardiac pressure dynamics — a clinically actionable hemodynamic biomarker enabling early therapeutic adjustments and personalized care. We work closely with leading hemodynamic experts to design robust …

182 similar entities Type: Startup Activities: healthtech deeptech Technologies: Data Analytics A.I.

Expertise - Prevention - Innovation Axelife is a 100% French Medtech, specialized in the field of assessment and prevention of cardiovascular risks. We design and develop assessment and prevention solutions, our first medical device: the pOpmeter, allows us to measure the Gold Standard pulse wave velocity for the measurement of arterial stiffness. The DM is class IIa and the company is ISO 13485. Our scientific team works on algorithms to calculate arterial age and has participated in the publication of more than 30 scientific publications which have supported the value of measuring arterial stiffness.

72 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Transforming Health Care Delivery Everyday 360Medlink Inc. is a software company specialized in healthcare providing validated Digital Health Platforms and Digital Therapeutics (DTx) to optimize patient care and improve access to vulnerable populations. Founded in 2010, the company has been working with the world’s leading pharma/biotech companies and state government (US). Today our products are used by a wide range of clients, across the globe and are deployed in conditions such as cancer, psoriasis, HIV and chronic pain. Our solutions are: 1.TAVIE-Rx: A Digital Medicine to promote patient engagement and adherence. The ideal patient treatment companion for a personalized, culturally …

756 similar entities Type: SMB Activities: healthtech deeptech it services Technologies: Data Analytics

The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. …

277 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Overwhelming evidence backs oesophageal Doppler. Now Deltex offers haemodynamic monitoring in all clinical settings. Deltex Medical is a global leader in haemodynamic monitoring technology. Its unique oesophageal Doppler monitoring (ODM) platform delivers accurate, real time information to guide anaesthetists on administration of fluid and drugs in surgical patients. ODM is supported by unsurpassed clinical evidence from many peer-reviewed trials. The ODM system is proven to help clinicians deliver improved surgical outcomes, fewer complications and shorter patient stay in hospital. The latest randomised, controlled, multicentre study, FEDORA, saw overall risk of complication halved, and even more dramatic reduction in specific complications …

65 similar entities Type: SMB Activities: healthtech deeptech Technologies: SaaS

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem. The Company’s flagship products, ProNephro AKITM and The NGAL TestTM, are based …

137 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Supporting Pharmaceutical, Clinical Research, and Biotechnology companies optimise drug research and development. Minervate is a global GxP compliance and technological solutions company. We provide bespoke digital solutions helping your company deliver safe high-quality medicines to patients and maintaining patient safety, quality and integrity. Speed in clinical development shouldn’t come at the cost of patient safety. At Minervate, our digital solutions bridge that gap. We combine rigorous compliance with globally-scaled tech to: Accelerate study timelines. Ensure participant safety. Reduce costs and carbon footprints. Delivering better health outcomes, faster. Data Analytics, QMS Development and Implementation, Computer Systems Validation, Data Analytics, Electronic Data …

113 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Enlightened blood-pressure management Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrackTM, our lead diagnostic device, is powered our proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. ViTrack, with data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, enables early intervention prior to acute events. Biomedical, cardiovascular, cNIBP, …

81 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Expertise that matters Mercodia is a Swedish life science company and experienced bioanalytical CRO with over 30 years in the field, specializing in analytical solutions for large molecule therapeutics and biomarkers. We develop and manufacture high-quality immunoassays for research and clinical diagnostics, with a core focus on biomarkers for diabetes, obesity, and cardiometabolic diseases. From our GLP-compliant laboratories in Europe and the US, we provide cost-effective bioanalytical services spanning preclinical to clinical phases of drug development programs. We support pharmaceutical, biotech, and academic teams by ensuring regulatory compliance while optimizing cost and efficiency. Renowned for our reliability, scientific expertise, and …

89 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Cloud Based Haematology Diagnostics Delivered aaS RheoDx is a diagnostics company committed to improving the quality of life of hematology patients and the efficiency in their clinical management. Develops an inexpensive medical device that monitors red blood cells conditions in less than five minutes with a drop. Its small size and simplicity allow to be used at the point-of-care and at home. Spin-off of the Centre Recerca Matemàtica (CRM), and incorporated in the Collider, the venture builder of tech transfer by Mobile World Capital Foundation. Medical Devices, In vitro diagnostics, Hematology, Point-of-care, Transfusions, and Blood cells conditions

202 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD …

208 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

We design, develop, and manufacture world-class products for diabetes care. We've manufactured over 8 million devices, three billion sensors, and developed the first FDA-cleared blood glucose meter/app for iPhone®. We've been featured by the New York Times and Fast Company, and work with some of the world's largest retailers (CVS, Kroger) and pharmaceutical companies (Sanofi, Perrigo) to change the way diabetes is treated. We have a vision for shaping the diabetes market through continuous innovations in biosensor technology and blood glucose monitoring. Our A-team of scientists, designers, and engineers will help to deliver solutions in connected health, high accuracy blood …

68 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Sensors

Reading the biological software to predict clinical success. ekei labs is an AI and laboratory company reading the biological software to predict clinical success and extend human lifespan. Advanced therapy development is bottlenecked by a 90% clinical trial failure rate because the industry lacks the early signals needed to predict success. To solve this, we engineered a biological search engine that physically isolates signal from genomic noise. For Drug Development, we provide the critical answers required by regulators and shareholders regarding cell potency, safety, and mechanism of action. For Manufacturing, we deliver the high-resolution identity and potency data needed to …

52 similar entities Type: Startup Activities: it services Technologies: SaaS

Protecting patients, sample by sample Industry leaders in patient sample management and traceability. Improving patient safety and AP lab workflow by advancing sample chain-of-custody. #patientsafety The Dreampath portfolio is built upon: -The importance patient safety and advancing it through proper chain-of-custody for patient samples in the anatomic pathology (AP) lab -The need for robust, reliable, and accurate access to samples in the AP lab (both clinical and research environments) -Fina, Crystal and Hydra track and monitor patient samples in the laboratory workflow, from receipt to diagnosis www.dreampathdx.net YouTube: @DreampathDiagnostics Twitter: @DreampathDx

58 similar entities Type: Startup Activities: healthtech deeptech

Multiplex blood testing platform to monitor chronic diseases like heart failure Project co-funded by the European Union Founded in 2019, Omini is developing the first point-of-care blood biomarker monitoring platform to transform the lives of patients suffering from chronic diseases, using its unique multiplex electrochemical biosensor technology. Multiplexing provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions. The affordable device combines a portable reader and single-use test strips, similar to a glucometer, simultaneously measuring four to ten blood biomarkers from a single capillary blood sample. It can be …

183 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Data Analytics

Our mission is to accelerate tomorrow’s treatment together MonolixSuite is a powerful, fast, and easy-to-use suite of applications designed for model-informed drug development. With fully interoperable tools for non-compartmental analysis, bioequivalence, population PK/PD modeling, and clinical trial simulations, MonolixSuite accelerates decision-making. It drives smarter, faster, and more effective drug development to improve patient outcomes worldwide Statistics, Pharmacometrics, Modelling and Simulation, Business software, Clinical trials, PKPD, and Non-compartmental analysis

115 similar entities Type: Startup Activities: biotech deeptech it services Technologies: Data Analytics

SaaS Platform Revolutionizing Clinical Trials Through Better Drug Exposure At AARDEX Group, we believe in the power of digital solutions to revolutionize the way we measure and manage medication adherence. We're not just talking the talk; we're walking the walk as the world leader in this space. Our cutting-edge technology, MEMS® Adherence Software (MEMS AS®), is the cornerstone of a comprehensive ecosystem designed to deliver accurate, data-driven adherence analytics across all forms of drug administration. But we don't stop there. Our team is dedicated to continuously innovating and pushing the boundaries of what's possible in the world of clinical trials. …

81 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Data Analytics

Amplio Pharma is a novel and exciting product company developing improved versions of already great drugs. Amplio Pharma is a novel and exciting product company developing improved versions of already great drugs. Amplio Pharma is a privately owned wholly women founded pharmaceutical company. Our vision is to develop and apply modern-day technology to fix the short-comings from drugs that otherwise have a proven track record in their disease area. Our first development candidate, NovoBioJect (AMP101), is being developed to boost the responder rate to current 1st line RA treatment from ca 35% to up to 70%. We intend to reach …

120 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Catalyzing Healthcare Breakthroughs Through Data Synergy We're dismantling information silos and facilitating unparalleled access to diverse, high-quality datasets. Leading life science companies in the US and Europe are already leveraging our service to push boundaries in tissue imaging, pathology software, and therapeutics. The landscape of precision medicine and biotechnology is evolving rapidly. CorpusAnalytiX ensures you're not just keeping pace, but setting the tempo. Healthcare, Data Marketplace, and Biotech

283 similar entities Type: Startup Activities: healthtech deeptech Technologies: Data Analytics

A patient focused, discovery driven life science company. Our mission is to bring clarity to complex autoimmune diseases by empowering physicians, and our partners across healthcare and biopharma, with advanced testing solutions that enable earlier, more accurate diagnoses and better patient outcomes. Through our AVISE® testing portfolio, we deliver the industry’s most comprehensive rheumatology diagnostic platform — integrating serology, cell-based assays, proprietary biomarkers, and a validated algorithm. Exagen is the only company to offer CB-CAPS, T Cell markers, anti-PAD4 and anti-RA33 testing commercially, and the pioneer in clinically validating these biomarkers for SLE and rheumatoid arthritis (RA), respectively. We also …

98 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Decoding Metabolic Health with Explainable AI At MedInsights, we are dedicated to bringing optimized therapeutic options for patients suffering from metabolic, cardiometabolic, neurometabolic and rare diseases with high unmet needs. Our internal drug repositioning engine, NexusRx, serves as a cornerstone for our discovery research, employing internal sets of proprietary algorithms to detect unknown and unforeseen relationships between disease-targets-drugs. This opens up preclinical validation opportunities which we perform in close partnerships with our academic collaborators. We envision to perform clinical trials and bring therapeutics from lab to bed side. Crunchbase profile: https://www.crunchbase.com/organization/medinsights-0569 Biotech, Data Science, Healthcare, Computer Vision, Generative AI, Network …

525 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Data Analytics

Digital life sciences company with a focus on adverse events in oncology drug trials. Eupnoos is building a safety intelligence layer for clinical trials — using a simple breath test to detect early signs of patient deterioration. Our proprietary clinical-grade measurement tools, SounDx Vita and Puffin (paediatric), turn a smartphone into a physiological assessment device. In just 10–15 seconds, patients perform a guided breathing manoeuvre, allowing us to extract objective signals such as airflow, lung restriction, and fluid in the lungs — measurements that would otherwise require multiple tests or hospital visits. What makes Eupnoos unique is that we do …

110 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning Data Analytics

Rapid Answers For Better Treatment Our vision is to enable rapid and local tests for anticoagulants at the point-of-care to benefit patients. Currently, there is no readily available solutions to address blood levels of anticoagulants called Direct Oral Anticoagulants (DOACs) at the point-of-care. We have developed a novel technology, chip and instrument that can detect anticoagulants, directly from whole blood within only 10 minutes. The elegant simplicity of our solution will potentially be readily available at the point of care.

55 similar entities Type: Startup Activities: healthtech deeptech

Data-driven healthcare DNAlytics builds data-driven software and analytics for healthcare and life sciences — turning complex biological and clinical data into decisions that compound over time. We work across three domains: BIOMANUFACTURING INTELLIGENCE Hercule is our on-premise biomanufacturing data platform for biotech and CDMOs. It combines electronic batch records (ISA S88-structured), automated Continued Process Verification (CPV), DoE, and ML modelling in one GMP-validated system — deployable in weeks, on your own server. Proof points from live deployments: · +15% productivity identified in 10 years of structured batch data — surfaced by Hercule in weeks · ~40% reduction in bioprocess development …

148 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: A.I. A.I. - Machine Learning Data Analytics

Proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes ZiO Health is a medical technology and digital health company developing proprietary, pocket-sized diagnostic tools. Our technology brings lab-grade testing directly to the point of use, supporting both single-point and continuous monitoring across a range of clinical applications. Core areas of focus: Heart failure screening and management Antibiotic susceptibility testing Therapeutic drug monitoring and precision dosing biotechnology, healthtech, health, biotech, medtech, biosensor, therapeuticdrugmonitoring, pointofcare, personalisedhealth, precision health, deeptech, and healthinnovation

171 similar entities Type: Startup Activities: healthtech biotech Technologies: A.I.

SynapCon develops & distributes software for clinical trials, making the process faster, better and more cost-effective. We digitise the entire process of pharma, biotech or medtech clinical trials, making them easier to manage, much faster and much more cost effective! Saving millions of patients and healthcare dollars through better access to medicines and medical devices worldwide. AUDITED QUALIFIED SUPPLIER 2022/2023. Thanks to the EMA's recent Notice to Sponsors, there has never been a better time for our product to demonstrate its capabilities. Clinical Research, EU-GDPR, Compliance Management, Artificial Intelligence, CROIT (Clinical Research Operations Information Technology), Consultancy (Medical Development and IT), …

376 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning

Empowering the next generation of clinical genomics: Monogenic + Polygenic Allelica develops clinical Polygenic Risk Score (PRS) tests to prevent cardiovascular disease and cancer. Our diagnostics are used by leading healthcare institutions in the US and internationally to identify high-risk individuals who benefit from personalized prevention and screening plans. We also operate through a decentralized model, enabling clinical genetics laboratories to develop and deliver their own PRS-based diagnostics with confidence. Working with leaders in the field, such as Baylor College of Medicine, we have set the industry standard for developing clinical PRS tests, ensuring quality and regulatory compliance at every …

125 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

Transforming kidney disease care with one simple blood test. Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosisTM for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isn’t.TM

62 similar entities Type: Startup Activities: healthtech deeptech Technologies: Data Analytics

Molecular Diagnostics Innovations ADOR Diagnostics is an innovative IVD company that specializes in the development of cutting-edge syndromic multiplex molecular biology diagnostics technology. ADOR sets a new standard by revolutionizing the way laboratories worldwide diagnose infectious diseases with multiplex,sample-to-answer, fully automated systems that deliver accurate results rapidly. By using ADOR’s systems, laboratories can reduce costs and increase efficiency while doctors are able to treat patients with confidence, knowing they would prescribe the correct antibiotics and the right treatment. The NATlab system is a multiplex isothermal (RCA) based cutting-edge molecular biology platform with a bench-top modular analyzer and a disposable all-included …

63 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: SaaS

Advanced heart failure monitoring in a simple step. Bodyport is on a mission to empower every person to live free from complex chronic conditions — by delivering actionable insights gleaned from unique health signals and simple, at-home experiences. We’re advancing the standard of care for complex chronic conditions like heart failure. By integrating a sophisticated biomarker platform into simple, easy-to-use devices, we help patients and their care teams better predict, understand, and intervene in changes to heart health — keeping people healthier and out of the hospital. With one simple step, our platform noninvasively measures a broad spectrum of hemodynamic …

83 similar entities Type: Startup Activities: healthtech Technologies: SaaS

The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class: BAPAIs for BrainAminopeptidase A Inhibitors. We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure. High blood pressure remains a major public health concern. Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A. The mid-term strategic objective of the company is to …

62 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Your Breath, Your Health PulmoBioMed commercialises state-of-the-art exhaled breath condensate & aerosol sampling technology as part of a platform for disease and environmental diagnostics. Our lead product, PBM-HALE is a passive fluid aerosol sampler engineered to segregate exhaled and environmental particles by size. Our technology solves key pains in avoiding sample contamination, preventing sample loss and generating highly reproducible data with digital molecular precision. The first of a series of products, PBM-HALE has demonstrated utility in biological agent capture, genomic/microbiomic analytics, and metabolomic profiling, through a one-stop solution. Our vision is to develop the first hand-held biomolecular analyser for medical, …

120 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Data Analytics

Award-winning company empowering patients through gold-standard rapid diagnostics Our mission is to revolutionise the field of diagnostics by providing rapid, accurate, and quantified point-of-care testing solutions. We strive to empower healthcare professionals with advanced technologies that enhance speed-to-care, leading to improved patient outcomes and ultimately saving lives. What We Have Delivered - A significant pipeline of tests currently focused on the most important global health challenges: Post-viral syndromes like Long Covid, COVID-19, Liver Health, Diabetes, Obesity, and Antimicrobial Resistance (AMR). Currently the Company’s Long Covid research test is available in the UK, Switzerland, Cyprus with plans to roll out in …

281 similar entities Type: Startup Activities: deeptech healthtech Technologies: Data Analytics

Choose us for our world-leading Bayesian dosing software. Stay with us for our best-in-class customer service. DoseMeRx is the world’s first (and largest) Bayesian dosing platform. We combine smart technology with science, leveraging clinically-validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype to accurately individualize a dose in seconds. Personalised dosing, Medical software, Precision dosing, Precision medicine, Dosing analytics, Bayesian dosing software, Clinical pharmacy, and Vancomycin

73 similar entities Type: Startup Activities: deeptech healthtech it services Technologies: SaaS

Recor Medical, headquartered in Palo Alto, Calif., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise system is FDA approved in the United States, bears the CE mark, and is an investigational device in Japan, hypertension, medical device, and Intervention cardiology

99 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Empowering Personalized Healthcare Aidar Health, Inc., is a healthcare technology and digital medicine company reimagining today’s standards for clinical trials, chronic care management, and health monitoring. Our rapid medical assessment device, MouthLab, is a non-invasive, hand-held, home monitoring device that measures more than 10 vital medical parameters in 30 seconds. Sensor data is sent in real-time using LTE-M or Bluetooth to our secure HIPAA-compliant cloud, where our proprietary analytics system uses AI and machine learning algorithms to analyze, and generate actionable insights. This data can then be accessed through a physician portal, which allows for timely intervention and treatment modification …

406 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics

Aidian develops, manufactures and markets diagnostic tests and test solutions. Aidian – Your aid in diagnostics We are a leading in vitro diagnostics (IVD) company established in 1974 in Finland. Specialising in point-of-care testing (POCT), we want to provide tools empowering healthcare professionals to make evidence-based diagnoses and treatment decisions. Our aim is to aid health globally by promoting efficient healthcare through accurate and fast diagnostics. We develop, manufacture, and distribute reliable and fast CE-marked diagnostic tests, especially for primary care. Our product portfolio includes solutions among others for infectious disease diagnostics, improved management of diabetes, and colorectal cancer screening. …

237 similar entities Type: SMB Activities: deeptech healthtech

The leading xAI-driven drug development company Ariana Pharma is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as Fluorescence-Activated Cell Sorting (FACS)), microbiota, Patient Reported Outcomes (PRO) as well as Real World Evidence (RWE) data. Combining advanced data analytics, drug development, and regulatory expertise, Ariana helps translate findings into innovative clinical development plans and …

64 similar entities Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics

The future of biomonitoring. Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter …

238 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a …

224 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

CE-, FDA- & TGA-approved medical app capable of detecting heart rhythm disorders FibriCheck is an innovative digital health company dedicated to transforming the way cardiac care is delivered. We do so by providing a medically certified, software-only and device-agnostic solution that redefines the way cardiac arrhythmias are detected and managed. We empower people to take control of their heart health by offering them our PPG-technology in a user-friendly setting. Users can measure their heart rhythm in 60 seconds, using the camera of their smartphone without any additional hardware. These measurements provide valuable insights into the heart rhythm which help people …

172 similar entities Type: Startup Activities: deeptech healthtech it services Technologies: Data Analytics

Fierce Medtech named C2N one of its Fierce 15 for 2020; "one of the most promising private companies in the industry.” C2N Diagnostics’ vision is to bring Clarity Through InnovationTM. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring. Its lead commercial product, the PrecivityADTM blood test, is a mass spectrometry-based test performed in C2N’s CLIA-certified lab that measures in blood multiple analytes including Aβ42, …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

World's leading digital assessment, therapy and biomarkers platform for Central Nervous System Conditions & Rare Disease Re-imagine clinical development through digital evidence generation with Beats Medical. Beats Medical are the world's leaders in digital assessments, therapies and biomarkers for Central Nervous System Conditions and Rare Disease. Our patented platform technology, Colbolt, provides frictionless access to gold standard assessments and therapies in real time, with an embedded digital biomarkers focus to help our partners unlock the breakthrough therapies of the future. Through the Beats Medical Colbolt platform, pharma partners can seamlessly integrate digital assessments and measures across the clinical development value …

75 similar entities Type: Startup Activities: deeptech healthtech Technologies: SaaS

Unique technology and novel data for personalized and optimal treatment of high cholesterol MONCYTE Health has a unique proprietary technology to quantify individual differences in cellular lipid uptake and storage which contribute to high blood cholesterol and the effectiveness of common lipid-lowering drugs. The readouts are derived from white blood cells, including monocytes, which play key roles in atherosclerotic plaque formation and inflammation, linking directly to cardiovascular risk. Precisely quantifying these individual differences enables personalized treatment strategies in combination with risk assessment which can help patients more effectively achieve optimal blood cholesterol levels faster, and thereby reduce the risk for …

66 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics Synthetic Biology

Smart.Safe.Samples - changing preanalytics from trust to evidence. smart. safe. samples It is all about the quality of medical decisions. S4DX closes the data gap between blood collection and lab analysis and enables a new quality standard for medical diagnostic decision making. We change preanalytics from a trust-based system into an evidence-based system. Our digital human sample fingerprint is a quantum leap forward for patient safety, the quality of medical decisions and lab testing efficiency. We create a trustworthy and verifiably basis for the personalized medicine of the future. healthcare, preanalytics, innovation, digital-preanalytics, phlebotomy-support, courier-support, healthcare, softwaredevelopment, IoT-loggers, medical-diagnostics, plattform-solution, …

85 similar entities Type: Startup Activities: healthtech deeptech Technologies: Data Analytics